查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813446

2032 年男性更年期支持市场预测：按产品类型、治疗方法、给药途径、疾病、分销管道和地区进行的全球分析

Male Menopause Support Market Forecasts to 2032 - Global Analysis By Product Type, Therapy Approach, Route of Administration, Disease, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球男性更年期支持市场预计在 2025 年达到 12.8 亿美元，预计到 2032 年将达到 20.1 亿美元，预测期内的复合年增长率为 6.7%。

男性更年期支持是指旨在控制与老龄化相关的睪固酮水平下降（通常称为男性更年期）相关症状的临床和生活方式干预措施。此类支持可能包括荷尔蒙补充疗法（用于缓解疲劳、情绪变化、性慾下降和肌肉萎缩）、心理咨商、营养指导和运动疗法。其目标是改善生活品质、恢復荷尔蒙平衡并降低相关的健康风险。由于症状的严重程度和潜在病因因人而异，因此个人化治疗至关重要。

大众对男性健康和老龄化的认识不断提高

公众意识宣传活动、名人代言和媒体报导正在鼓励男性寻求与男性更年期相关症状的帮助。这种转变推动了对标靶治疗的需求，包括睾酮替代疗法和心理干预。此外，医疗保健提供者越来越多地接受专门针对男性的健康计划，这反映出人们越来越接受与老龄化相关的挑战。关于疲劳、情绪变化和性健康的对话逐渐正常化，正在推动市场扩张。

缺乏医疗意识，症状不明确、特异性

易怒、性慾减退和睡眠障碍等症状常与其他疾病重迭，使诊断更加复杂。缺乏标准化的诊断标准，且医学课程的纳入有限，进一步阻碍了执业医师对此类疾病的认识。此外，许多男性由于耻辱感以及将症状错误地归咎于生活方式因素而推迟寻求帮助。这种诊断的不确定性限制了早期疗育，并延缓了专门支持措施的采用。

对自然和整体解决方案的需求不断增长

草药补充剂、适应原和基于生活方式的干预措施在寻求更安全、长期解决方案的老年男性中越来越受欢迎。该市场正在见证植物来源睪固酮增强剂、针灸通讯协定和综合健康计划的创新。各公司也正在投资针对荷尔蒙健康的个人化营养和健身。这一趋势与更广泛的预防性护理和自我管理老龄化运动相吻合，为整体产品系列铺平了道路。

科学和医学怀疑论

批评人士认为，与老龄化相关的荷尔蒙下降是一个自然过程，除非出现临床显着症状，否则无需干预。这种怀疑态度影响了保险覆盖范围、监管核准以及医生的处方行为。此外，临床试验结果的不一致以及对荷尔蒙疗法长期安全性的担忧加剧了人们的犹豫。这种阻力可能会减缓创新，并限制市场在保守的医疗体系中扩张的能力。

COVID-19的影响：

疫情对男性更年期支持市场产生了双重影响。一方面，供应链中断和麵对面咨询的减少，导致诊断和治疗启动延迟。另一方面，这场危机加速了数位医疗的普及，使得远距症状追踪和虚拟咨询成为可能。居家隔离期间，男性开始更加关注自身的身心健康，对健康解决方案的兴趣也随之增加。远端医疗平台开始提供客製化的荷尔蒙评估和治疗方案，扩大了医疗服务的可近性。

预测期内，荷尔蒙补充疗法(HRT) 细分市场预计将成为最大的细分市场

荷尔蒙补充疗法(HRT) 领域预计将在预测期内占据最大的市场份额，这得益于其在治疗睪固酮缺乏症方面已得到证实的有效性。经皮吸收贴片、凝胶和鼻喷雾等给药方式的创新提高了患者的依从性，并最大限度地减少了副作用。监管机构完善了 HRT 的使用指南，增强了医生的信心，并扩大了临床应用。该领域受益于强大的临床研究和消费者日益增长的积极应对荷尔蒙失衡的意愿。

预计心理咨商领域在预测期内的复合年增长率最高。

心理咨商领域预计将在预测期内实现最高成长率，反映出老年男性对心理健康的日益重视。认知行为疗法、支持小组和压力管理计画正在被整合到综合护理模式中。数位平台使咨询服务的可扩展性成为可能，并使其在城市以外的地区也能获得。围绕男性心理脆弱的污名化正逐渐消退，促使更多男性寻求心理支持。

占比最大的地区：

由于先进的医疗基础设施和强大的消费者意识，北美预计将在预测期内占据最大的市场份额。该地区拥有提供男性健康计画的专业诊所，并在荷尔蒙疗法领域积极进行药物研发。睾酮替代疗法和心理健康服务的保险覆盖率更高，这支撑了市场渗透。此外，对与老龄化相关的健康问题的文化开放性也推动了早期采用支持性解决方案。

复合年增长率最高的地区：

由于人口结构变化和医疗保健投资的增加，预计亚太地区将在预测期内实现最高的复合年增长率。在中国、印度和韩国等国家，男性人口正在迅速老化，这增加了对特定年龄层干预措施的需求。阿育吠陀和传统中医等传统治疗体係正在与现代治疗方法结合，形成一种混合治疗模式。政府为促进男性健康和普及数位医疗所采取的措施正在推动市场扩张。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球男性更年期支持市场（依产品类型）

  • 荷尔蒙补充疗法（HRT）
    • 睾酮替代疗法
    • 睪酮凝胶和乳膏
    • 注射
    • 贴片和颗粒
    • DHEA补充剂
  • 营养补充品
    • 维生素补充剂
    • 矿物质补充剂
    • 草药补充剂
    • 多营养支持配方
  • 製药
  • 其他产品类型

6. 全球男性更年期支持市场（依治疗方法）

  • 生活方式的改变
  • 荷尔蒙疗法
  • 心理咨商
  • 替代医学
  • 其他治疗方法

7. 全球男性更年期支持市场（依给药途径）

  • 口服
  • 肠外
  • 经皮
  • 皮下

第八章全球男性更年期支持市场（按疾病）

  • 男性性腺功能低下症
  • 勃起功能障碍
  • 性慾下降
  • 老年男性雄性激素下降
  • 其他疾病

9. 全球男性更年期支持市场（依通路）

  • 健康与保健商店
  • 网路药局和电子商务
  • 零售药局和药局
  • 医院药房
  • 直接面向消费者（DTC）
  • 其他分销管道

第十章全球男性更年期支持市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • AbbVie Inc.
  • Pfizer Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Sun Pharmaceuticals Industries Ltd.
  • Novo Nordisk A/S
  • Merck & Co., Inc.
  • Renuva HRT & Wellness
  • TherapeuticsMD, Inc.
  • Marion Gluck Clinic
  • Health & Her
  • Zora Health
  • Halozyme Therapeutics, Inc.
  • Perrigo Company plc
  • Novartis AG
  • Endo International plc
  • Ferring Pharmaceuticals
  • Mylan NV
Product Code: SMRC30895

According to Stratistics MRC, the Global Male Menopause Support Market is accounted for $1.28 billion in 2025 and is expected to reach $2.01 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Male menopause support is the clinical and lifestyle interventions designed to manage symptoms associated with age-related testosterone decline, commonly termed andropause. This support may include hormone replacement therapy, psychological counseling, nutritional guidance, and exercise regimens to address fatigue, mood changes, reduced libido, and muscle loss. It aims to improve quality of life, restore hormonal balance, and mitigate associated health risks. Tailored approaches are essential, as symptom severity and underlying causes vary among individuals

Market Dynamics:

Driver:

Increasing public discourse around men's health and aging

Public awareness campaigns, celebrity endorsements, and media coverage are encouraging men to seek support for symptoms linked to andropause. This shift is fostering demand for targeted therapies, including testosterone replacement and psychological interventions. Moreover, healthcare providers are increasingly integrating male-specific wellness programs, reflecting a broader cultural acceptance of aging-related challenges. The normalization of conversations around fatigue, mood changes, and sexual health is catalyzing market expansion.

Restraint:

Lack of medical recognition & vague, non-specific symptoms

Symptoms such as irritability, low libido, and sleep disturbances often overlap with other conditions, making diagnosis complex. The absence of standardized diagnostic criteria and limited inclusion in medical curricula further hinder recognition among practitioners. Additionally, many men delay seeking help due to stigma or misattribution of symptoms to lifestyle factors. This diagnostic uncertainty restricts early intervention and slows adoption of specialized support solutions.

Opportunity:

Growing demand for natural and holistic solutions

Herbal supplements, adaptogens, and lifestyle-based interventions are gaining traction among aging men seeking safer, long-term solutions. The market is witnessing innovation in plant-based testosterone boosters, acupuncture protocols, and integrative wellness programs. Companies are also investing in personalized nutrition and fitness platforms tailored to hormonal health. This trend aligns with the broader movement toward preventive care and self-managed aging, opening avenues for holistic product portfolios.

Threat:

Scientific and medical skepticism

Critics argue that age-related hormonal decline is a natural process, not requiring intervention unless clinically severe. This skepticism affects insurance coverage, regulatory approvals, and physician prescribing behavior. Furthermore, inconsistent clinical trial outcomes and concerns over long-term safety of hormone therapies contribute to hesitancy. Such resistance may slow innovation and limit the market's ability to scale across conservative healthcare systems.

Covid-19 Impact:

The pandemic had a dual impact on the male menopause support market. On one hand, disruptions in supply chains and reduced in-person consultations delayed diagnoses and treatment initiation. On the other, the crisis accelerated digital health adoption, enabling remote symptom tracking and virtual counseling. Men became more attuned to their mental and physical health during lockdowns, prompting increased interest in wellness solutions. Telemedicine platforms began offering tailored hormonal assessments and therapy plans, expanding access to care.

The hormone replacement therapy (HRT) segment is expected to be the largest during the forecast period

The hormone replacement therapy (HRT) segment is expected to account for the largest market share during the forecast period due to its established efficacy in managing testosterone deficiency. Innovations in delivery formats such as transdermal patches, gels, and nasal sprays are improving patient adherence and minimizing side effects. Regulatory bodies are refining guidelines for HRT use, enhancing physician confidence and expanding its clinical application. The segment benefits from robust clinical research and growing consumer willingness to address hormonal imbalances proactively.

The psychological counseling segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the psychological counseling segment is predicted to witness the highest growth rate reflecting the rising emphasis on mental health in aging men. Cognitive behavioral therapy, support groups, and stress management programs are being integrated into comprehensive care models. Digital platforms are enabling scalable delivery of counseling services, making them accessible beyond urban centers. The stigma around male emotional vulnerability is gradually eroding, encouraging more men to seek psychological support.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by advanced healthcare infrastructure and high consumer awareness. The region has a strong presence of specialized clinics offering male wellness programs, alongside active pharmaceutical R&D in hormone therapies. Insurance coverage for testosterone replacement and mental health services is more prevalent, supporting market penetration. Additionally, cultural openness toward aging-related health issues fosters early adoption of support solutions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by demographic shifts and increasing healthcare investments. Countries like China, India, and South Korea are witnessing a surge in aging male populations, prompting demand for age-specific interventions. Traditional medicine systems such as Ayurveda and Traditional Chinese Medicine are being integrated with modern therapies, creating hybrid treatment models. Government initiatives promoting men's health and digital healthcare access are accelerating market expansion.

Key players in the market

Some of the key players in Male Menopause Support Market include AbbVie Inc., Pfizer Inc., Bayer AG, Eli Lilly and Company, Sun Pharmaceuticals Industries Ltd., Novo Nordisk A/S, Merck & Co., Inc., Renuva HRT & Wellness, TherapeuticsMD, Inc., Marion Gluck Clinic, Health & Her, Zora Health, Halozyme Therapeutics, Inc., Perrigo Company plc, Novartis AG, Endo International plc, Ferring Pharmaceuticals, and Mylan N.V.

Key Developments:

In May 2025, Sun Pharma announced completion of its acquisition of Checkpoint Therapeutics, Inc., expanding its oncology and specialty portfolio. The company also published Q4/FY results in May and management updates tied to integration and future pipeline plans.

In May 2025, Pfizer entered an exclusive global (ex-China) licensing agreement with 3SBio to develop, manufacture and commercialize SSGJ-707, a PD-1/VEGF bispecific currently in China trials. The deal gives Pfizer global rights outside China and includes options on China commercialization; Pfizer emphasized oncology pipeline expansion.

In May 2025, AbbVie announced FDA accelerated approval of EMRELIS(TM) (telisotuzumab vedotin-tllv) for adults with previously treated advanced non-small-cell lung cancer (NSCLC) with high c-Met protein overexpression.

Product Types Covered:

  • Hormone Replacement Therapy (HRT)
  • Dietary Supplements
  • Pharmaceuticals
  • Other Product Types

Therapy Approaches Covered:

  • Lifestyle Modifications
  • Hormonal Therapy
  • Psychological Counseling
  • Alternative Medicine
  • Other Therapy Approaches

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Transdermal
  • Subcutaneous

Diseases Covered:

  • Male Hypogonadism
  • Erectile Dysfunction
  • Loss of Libido
  • Androgen Decline in the Aging Male
  • Other Diseases

Distribution Channels Covered:

  • Health & Wellness Stores
  • Online Pharmacies & E-commerce
  • Retail Pharmacies & Drug Stores
  • Hospital Pharmacies
  • Direct-to-Consumer (DTC) Sales
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Male Menopause Support Market, By Product Type

  • 5.1 Introduction
  • 5.2 Hormone Replacement Therapy (HRT)
    • 5.2.1 Testosterone Replacement Therapy
    • 5.2.2 Testosterone Gels & Creams
    • 5.2.3 Injections
    • 5.2.4 Patches & Pellets
    • 5.2.5 DHEA Supplements
  • 5.3 Dietary Supplements
    • 5.3.1 Vitamin Supplements
    • 5.3.2 Mineral Supplements
    • 5.3.3 Herbal Supplements
    • 5.3.4 Multi-nutrient Support Formulas
  • 5.4 Pharmaceuticals
  • 5.5 Other Product Types

6 Global Male Menopause Support Market, By Therapy Approach

  • 6.1 Introduction
  • 6.2 Lifestyle Modifications
  • 6.3 Hormonal Therapy
  • 6.4 Psychological Counseling
  • 6.5 Alternative Medicine
  • 6.6 Other Therapy Approaches

7 Global Male Menopause Support Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Transdermal
  • 7.5 Subcutaneous

8 Global Male Menopause Support Market, By Disease

  • 8.1 Introduction
  • 8.2 Male Hypogonadism
  • 8.3 Erectile Dysfunction
  • 8.4 Loss of Libido
  • 8.5 Androgen Decline in the Aging Male
  • 8.6 Other Diseases

9 Global Male Menopause Support Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Health & Wellness Stores
  • 9.3 Online Pharmacies & E-commerce
  • 9.4 Retail Pharmacies & Drug Stores
  • 9.5 Hospital Pharmacies
  • 9.6 Direct-to-Consumer (DTC) Sales
  • 9.7 Other Distribution Channels

10 Global Male Menopause Support Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AbbVie Inc.
  • 12.2 Pfizer Inc.
  • 12.3 Bayer AG
  • 12.4 Eli Lilly and Company
  • 12.5 Sun Pharmaceuticals Industries Ltd.
  • 12.6 Novo Nordisk A/S
  • 12.7 Merck & Co., Inc.
  • 12.8 Renuva HRT & Wellness
  • 12.9 TherapeuticsMD, Inc.
  • 12.10 Marion Gluck Clinic
  • 12.11 Health & Her
  • 12.12 Zora Health
  • 12.13 Halozyme Therapeutics, Inc.
  • 12.14 Perrigo Company plc
  • 12.15 Novartis AG
  • 12.16 Endo International plc
  • 12.17 Ferring Pharmaceuticals
  • 12.18 Mylan N.V

List of Tables

  • Table 1 Global Male Menopause Support Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Male Menopause Support Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Male Menopause Support Market Outlook, By Hormone Replacement Therapy (HRT) (2024-2032) ($MN)
  • Table 4 Global Male Menopause Support Market Outlook, By Testosterone Replacement Therapy (2024-2032) ($MN)
  • Table 5 Global Male Menopause Support Market Outlook, By Testosterone Gels & Creams (2024-2032) ($MN)
  • Table 6 Global Male Menopause Support Market Outlook, By Injections (2024-2032) ($MN)
  • Table 7 Global Male Menopause Support Market Outlook, By Patches & Pellets (2024-2032) ($MN)
  • Table 8 Global Male Menopause Support Market Outlook, By DHEA Supplements (2024-2032) ($MN)
  • Table 9 Global Male Menopause Support Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 10 Global Male Menopause Support Market Outlook, By Vitamin Supplements (2024-2032) ($MN)
  • Table 11 Global Male Menopause Support Market Outlook, By Mineral Supplements (2024-2032) ($MN)
  • Table 12 Global Male Menopause Support Market Outlook, By Herbal Supplements (2024-2032) ($MN)
  • Table 13 Global Male Menopause Support Market Outlook, By Multi-nutrient Support Formulas (2024-2032) ($MN)
  • Table 14 Global Male Menopause Support Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 15 Global Male Menopause Support Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 16 Global Male Menopause Support Market Outlook, By Therapy Approach (2024-2032) ($MN)
  • Table 17 Global Male Menopause Support Market Outlook, By Lifestyle Modifications (2024-2032) ($MN)
  • Table 18 Global Male Menopause Support Market Outlook, By Hormonal Therapy (2024-2032) ($MN)
  • Table 19 Global Male Menopause Support Market Outlook, By Psychological Counseling (2024-2032) ($MN)
  • Table 20 Global Male Menopause Support Market Outlook, By Alternative Medicine (2024-2032) ($MN)
  • Table 21 Global Male Menopause Support Market Outlook, By Other Therapy Approaches (2024-2032) ($MN)
  • Table 22 Global Male Menopause Support Market Outlook, By Route of Administration (2024-2032) ($MN)
  • Table 23 Global Male Menopause Support Market Outlook, By Oral (2024-2032) ($MN)
  • Table 24 Global Male Menopause Support Market Outlook, By Parenteral (2024-2032) ($MN)
  • Table 25 Global Male Menopause Support Market Outlook, By Transdermal (2024-2032) ($MN)
  • Table 26 Global Male Menopause Support Market Outlook, By Subcutaneous (2024-2032) ($MN)
  • Table 27 Global Male Menopause Support Market Outlook, By Disease (2024-2032) ($MN)
  • Table 28 Global Male Menopause Support Market Outlook, By Male Hypogonadism (2024-2032) ($MN)
  • Table 29 Global Male Menopause Support Market Outlook, By Erectile Dysfunction (2024-2032) ($MN)
  • Table 30 Global Male Menopause Support Market Outlook, By Loss of Libido (2024-2032) ($MN)
  • Table 31 Global Male Menopause Support Market Outlook, By Androgen Decline in the Aging Male (2024-2032) ($MN)
  • Table 32 Global Male Menopause Support Market Outlook, By Other Diseases (2024-2032) ($MN)
  • Table 33 Global Male Menopause Support Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 34 Global Male Menopause Support Market Outlook, By Health & Wellness Stores (2024-2032) ($MN)
  • Table 35 Global Male Menopause Support Market Outlook, By Online Pharmacies & E-commerce (2024-2032) ($MN)
  • Table 36 Global Male Menopause Support Market Outlook, By Retail Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 37 Global Male Menopause Support Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 38 Global Male Menopause Support Market Outlook, By Direct-to-Consumer (DTC) Sales (2024-2032) ($MN)
  • Table 39 Global Male Menopause Support Market Outlook, By Other Distribution Channels (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.